<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01675310</url>
  </required_header>
  <id_info>
    <org_study_id>Conacyt 151819</org_study_id>
    <secondary_id>INPer (Mexico)</secondary_id>
    <nct_id>NCT01675310</nct_id>
  </id_info>
  <brief_title>Medical Nutrition Therapy Plus Transgestational Metformin For Preventing Gestational Diabetes In High Risk Mexican Women</brief_title>
  <official_title>EFFECTIVITY OF MEDICAL NUTRITION THERAPY PLUS TRANSGESTATIONAL METFORMIN FOR PREVENTING THE INCIDENCE OF GESTATIONAL DIABETES MELLITUS IN HIGH RISK MEXICAN WOMEN.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Council of Science and Technology, Mexico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gestational diabetes mellitus is one of the most frequent complications of pregnancy, that
      affect between 1 to 14% of population around the world.

      There is a few studies to prevent gestational diabetes mellitus in high risk women as Mexican
      population.

      Metformin has been used during pregnancy in women with gestational diabetes and women with
      polycystic ovary syndrome, with acceptable security for mother and fetus.

      Metformin decrease the insulin resistance and weight gain, we believe that metformin may be
      decrease the risk of gestational diabetes mellitus in high risk women.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gestational diabetes mellitus</measure>
    <time_frame>27-28 weeks of gestation</time_frame>
    <description>oral glucose tolerance test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>insulin resistance</measure>
    <time_frame>At birth</time_frame>
    <description>measure of insulin resistance by HOMA-IR, sample of umbilical cord</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Pregestational Obesity (BMI &gt; 27kg/m2)</condition>
  <condition>History of Polycystic Ovary Syndrome</condition>
  <arm_group>
    <arm_group_label>medical nutrition therapy + metformin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>medical nutrition therapy plus trans-gestational metformin (850mg 2 times day)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>medical nutrition therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>medical nutrition therapy without trans-gestational metformin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>medical nutrition therapy + metformin</intervention_name>
    <arm_group_label>medical nutrition therapy + metformin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Medical nutrition therapy</intervention_name>
    <description>medical nutrition therapy</description>
    <arm_group_label>medical nutrition therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Mexican women with pregnancy &lt; 16 weeks of gestation, normal oral glucose tolerance
             75g-2h test and 3 or more criteria:

               1. Body mass index &gt; 27 kg/m2

               2. Maternal age &gt;25

               3. History of infertility with polycystic ovary syndrome

               4. History of macrosomic newborn (Weight &gt;4000g)

               5. History of diabetes mellitus in first or second degree.

               6. History of gestational diabetes in previous pregnancy

        Exclusion Criteria:

          -  Any form of pregestational diabetes

          -  Fasting glucose &gt; 126 mg/dL at first prenatal visit.

          -  seric creatinine &gt; 1.5 mg/dL

          -  Hyperthyroidism

          -  Heart disease

          -  Hepatic disease

          -  Renal diseases

          -  Epilepsy

          -  Lupus

          -  Chronic hypertension.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Enrique Reyes-Mu√±oz, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Institute of Perinatology, Mexico City</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Institute of Perinatology</name>
      <address>
        <city>Mexico</city>
        <zip>11000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <link>
    <url>http://journals.lww.com/greenjournal/Abstract/2014/05001/Medical_Nutrition_Therapy_Plus_Metformin_for.346.aspx</url>
    <description>Medical Nutrition Therapy Plus Metformin for Preventing Gestational Diabetes Among High-Risk Women.</description>
  </link>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 27, 2012</study_first_submitted>
  <study_first_submitted_qc>August 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 29, 2012</study_first_posted>
  <last_update_submitted>March 23, 2015</last_update_submitted>
  <last_update_submitted_qc>March 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 25, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes</investigator_affiliation>
    <investigator_full_name>ENRIQUE REYES-Munoz MD</investigator_full_name>
    <investigator_title>Clinical Reseach</investigator_title>
  </responsible_party>
  <keyword>obesity, polycystic ovary syndrome, gestational diabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
    <mesh_term>Diabetes, Gestational</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metformin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

